Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825260 | Clinical Therapeutics | 2014 | 8 Pages |
Abstract
Patients taking duloxetine for OA or CLBP who have <10% reduction in pain after 4 weeks of treatment have limited possibility for eventually achieving even moderate pain reduction by the end of 12 weeks. ClinicalTrials.gov identifier: NCT00433290, NCT00408421, NCT00424593, NCT00408876, NCT00767806.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Owen D. MBBS, Melissa MD, Dustin D. PhD, Jonna PhD, Anthony MD, Doron MD, Madelaine M. MD,